CLFD · Clearfield, Inc.
What's happening
- CLFD is down 0.56% today, trading at $29.20. — Live quote
- Volume today (5,970) is well below its 3-month average of 180,180. (Finnhub fundamentals)
- Reports earnings on 2026-11-05 (after market close), 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.22 actual vs. $0.19 estimated (+15.5%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Aggregate ratings for 2026-10-01 (10 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Earnings Trends (Quarterly EPS Actual vs Estimate)
Valuation Measures & Ratios
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Dec '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $540.1M | $349.6M | $446.0M | $634.7M | $438.4M |
| P/E | 155.93 | 195.20 | 1079.89 | 1094.37 | -63.20 |
| Price/Sales | 3.57 | 2.36 | 3.11 | 4.02 | 2.81 |
| Price/Book | 2.20 | 1.44 | 1.79 | 2.40 | 1.65 |
| EV/Revenue | 3.43 | 2.30 | 3.01 | 3.82 | 2.64 |
| EV/EBITDA | 78.15 | 59.10 | 75.58 | — | — |
| ROE | 1.41% | 0.74% | 0.17% | 0.22% | -2.61% |
| ROA | 1.30% | 0.68% | 0.15% | 0.18% | -2.23% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-10-20; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -12.1% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -5.5%. Finnhub fundamentals ↗
- Trailing 52-week price return is -16.6%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on CLFD
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Dec '25 | Jun '25 | Mar '25 | Dec '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $43.9M | $34.4M | $34.3M | $38.8M | $40.6M | $29.7M | $48.8M | $36.9M |
| Gross profit | $13.9M | $11.2M | $11.4M | $13.7M | $14.0M | $8.7M | $10.7M | $2.8M |
| Operating income | $2.6M | -$2.1M | -$1.8M | $1.5M | $1.7M | -$2.0M | -$2.3M | -$9.7M |
| Net income | $3.0M | -$528.0K | -$614.0K | $1.6M | $1.3M | -$1.9M | -$447.0K | -$5.9M |
| EPS (diluted) | $0.22 | $-0.04 | $-0.04 | $0.11 | $0.09 | $-0.13 | $-0.04 | $-0.40 |
| EPS (basic) | $0.22 | $-0.04 | $-0.04 | $0.11 | $0.09 | $-0.13 | $-0.04 | $-0.40 |
| Operating margin | $6 | -$6 | -$5 | $4 | $4 | -$7 | -$5 | -$26 |
| Net margin | $7 | -$2 | -$2 | $4 | $3 | -$6 | -$1 | -$16 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $267.1M | $263.5M | $268.1M | $306.2M | $314.7M | $310.9M | $303.2M | $315.3M |
| Total liabilities | $21.2M | $20.7M | $18.4M | $50.0M | $50.2M | $45.0M | $35.8M | $39.5M |
| Stockholders' equity | $245.9M | $242.8M | $249.7M | $256.2M | $264.5M | $265.9M | $267.4M | $275.8M |
| Total current assets | $170.9M | $163.0M | $165.7M | $198.5M | $212.6M | $206.3M | $197.9M | $229.6M |
| Total current liabilities | $13.6M | $12.7M | $13.2M | $36.6M | $35.9M | $30.5M | $18.7M | $24.4M |
| Cash & equivalents | $20.4M | $9.4M | $13.9M | $21.5M | $33.9M | $28.8M | $30.5M | $14.1M |
| Marketable securities (current) | $80.8M | $81.7M | $82.6M | $84.5M | $83.4M | $83.1M | $82.6M | $114.8M |
| Accounts receivable | $22.1M | $20.9M | $15.0M | $18.0M | $26.6M | $24.2M | $14.1M | $13.8M |
| Inventory | $33.4M | $36.9M | $40.2M | $42.0M | $53.8M | $56.1M | $59.2M | $56.1M |
| Other current assets | $14.2M | $14.1M | $14.1M | $11.2M | $15.0M | $14.0M | $11.6M | $10.5M |
| Marketable securities (non-current) | $53.9M | $56.0M | $60.3M | $59.8M | $40.2M | $41.4M | $41.9M | $24.5M |
| Property, plant & equipment | $9.3M | $9.5M | $9.5M | $9.7M | $19.7M | $25.2M | $23.7M | $15.9M |
| Goodwill | — | — | — | $4.7M | $6.7M | $6.6M | $6.5M | $6.6M |
| Intangible assets | $7.9M | $8.4M | $8.9M | $9.4M | $10.7M | $5.9M | $6.1M | $4.7M |
| Other non-current assets | $451.0K | $489.0K | $534.0K | $608.0K | $689.0K | $962.0K | $2.2M | $963.0K |
| Accounts payable | $5.1M | $3.7M | $3.9M | $7.0M | $8.7M | $8.7M | $4.3M | $2.8M |
| Accrued liabilities | $1.2M | $1.1M | $2.3M | $2.2M | $4.7M | $3.5M | $2.6M | $2.3M |
| Short-term debt | — | — | — | — | $2.4M | $2.2M | — | $0 |
| Long-term debt | — | — | — | — | $0 | $0 | $2.1M | $2.2M |
| Common stock & paid-in capital | $136.0K | $136.0K | $138.0K | $138.0K | $138.0K | $140.0K | $141.0K | $142.0K |
| Retained earnings | $108.8M | $105.8M | $106.3M | $106.9M | $116.0M | $114.4M | $113.1M | $115.0M |
| Accumulated other comprehensive income (loss) | -$339.0K | -$144.0K | $163.0K | $1.7M | $1.7M | $586.0K | -$17.0K | $1.1M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | — | — | — | $7.9M | $3.0M | $7.2M | $13.1M |
| Investing cash flow | — | — | — | — | $838.0K | -$2.2M | $13.4M | -$19.2M |
| Financing cash flow | — | — | — | — | -$3.6M | -$2.4M | -$6.4M | -$3.2M |
| Free cash flow | — | — | — | — | $7.5M | $654.0K | $5.1M | $5.9M |
| Capital expenditures | — | — | — | — | $407.0K | $2.4M | $2.1M | $7.2M |
| Depreciation & amortization | $1.6M | $1.6M | $1.6M | $1.4M | $1.7M | $1.5M | $1.5M | $4.3M |
| Share-based compensation | $1.0M | $1.3M | $1.3M | $1.2M | $1.2M | $1.2M | $1.1M | $938.0K |
| Deferred income taxes | — | — | — | $2.3M | — | — | — | -$3.5M |
| Change in accounts receivable | $1.2M | $5.9M | -$3.0M | $1.0M | -$2.0M | $8.1M | -$3.6M | -$5.5M |
| Change in inventory | -$3.5M | -$3.3M | -$1.8M | $1.4M | -$3.1M | -$5.7M | -$6.3M | -$3.0M |
| Purchases of investments | $18.2M | $32.1M | $20.0M | $40.4M | $19.5M | $20.2M | $39.0M | $35.3M |
| Sales/maturities of investments | — | — | — | — | — | — | — | — |
| Share repurchases | $897.0K | $7.3M | $5.3M | -$12.0K | $5.7M | $4.7M | $6.3M | $0 |
| Debt issued | — | — | — | — | $0 | — | — | — |
| Debt repaid | — | — | — | $0 | $0 | — | — | -$2.1M |
| Tax withholding on stock comp | $18.0K | $4.0K | $997.0K | $0 | $0 | $3.0K | $491.0K | $253.0K |
| Other financing activities | — | — | — | — | — | — | — | — |
Income statement
| Line item | Sep '25 | Sep '24 | Sep '23 | Sep '22 | Sep '21 |
|---|---|---|---|---|---|
| Revenue | $150.1M | $125.6M | $225.7M | $270.9M | $140.8M |
| Gross profit | $50.5M | $25.8M | $79.9M | $112.9M | $61.2M |
| Operating income | $2.1M | -$19.2M | $37.6M | $63.8M | $25.2M |
| Net income | -$8.1M | -$12.5M | $32.5M | $49.4M | $20.3M |
| EPS (diluted) | $-0.58 | $-0.85 | $2.17 | $3.55 | $1.47 |
| EPS (basic) | $-0.58 | $-0.85 | $2.17 | $3.58 | $1.48 |
| Operating margin | $1 | -$15 | $17 | $24 | $18 |
| Net margin | -$5 | -$10 | $14 | $18 | $14 |
Balance sheet
| Line item | Sep '25 | Sep '24 | Dec '23 | Sep '23 | Dec '22 |
|---|---|---|---|---|---|
| Total assets | $306.2M | $315.3M | — | $355.5M | — |
| Total liabilities | $50.0M | $39.5M | — | $40.4M | — |
| Stockholders' equity | $256.2M | $275.8M | — | $315.2M | — |
| Total current assets | $198.5M | $229.6M | — | $296.3M | — |
| Total current liabilities | $36.6M | $24.4M | — | $29.0M | — |
| Cash & equivalents | $21.5M | $14.1M | — | $37.8M | — |
| Marketable securities (current) | $84.5M | $114.8M | — | $130.3M | — |
| Accounts receivable | $18.0M | $13.8M | — | $28.4M | — |
| Inventory | $42.0M | $56.1M | — | $98.1M | — |
| Other current assets | $11.2M | $10.5M | — | $1.7M | — |
| Marketable securities (non-current) | $59.8M | $24.5M | — | $6.3M | — |
| Property, plant & equipment | $9.7M | $15.9M | — | $21.5M | — |
| Goodwill | $4.7M | $6.6M | $6.5M | $6.5M | $6.4M |
| Intangible assets | $9.4M | $4.7M | — | $6.1M | — |
| Other non-current assets | $608.0K | $963.0K | — | $1.9M | — |
| Accounts payable | $7.0M | $2.8M | — | $8.9M | — |
| Accrued liabilities | $2.2M | $2.3M | — | $2.4M | — |
| Common stock & paid-in capital | $138.0K | $142.0K | — | $153.0K | — |
| Retained earnings | $106.9M | $115.0M | — | $127.3M | — |
| Accumulated other comprehensive income (loss) | $1.7M | $1.1M | — | -$544.0K | — |
Cash flow
| Line item | Sep '25 | Sep '24 | Sep '23 | Sep '22 | Sep '21 |
|---|---|---|---|---|---|
| Operating cash flow | — | $22.2M | $18.4M | $2.3M | $10.9M |
| Investing cash flow | — | -$6.9M | -$112.2M | -$8.2M | -$13.6M |
| Financing cash flow | — | -$36.9M | $115.0M | $9.4M | -$536.0K |
| Free cash flow | — | $12.7M | $10.7M | -$6.2M | — |
| Capital expenditures | — | $9.6M | $7.7M | $8.5M | — |
| Depreciation & amortization | $6.1M | $5.9M | $4.6M | $3.4M | $2.3M |
| Share-based compensation | $4.6M | $4.4M | $3.6M | $2.3M | $1.3M |
| Deferred income taxes | $2.3M | -$3.5M | -$2.0M | -$334.0K | -$187.0K |
| Change in accounts receivable | $3.5M | -$6.5M | -$27.1M | $24.2M | $9.2M |
| Change in inventory | -$13.6M | -$26.5M | $11.1M | $43.7M | $13.1M |
| Purchases of investments | $119.1M | $159.4M | $210.9M | $248.0K | $24.8M |
| Share repurchases | $16.7M | $33.4M | $0 | $0 | $0 |
| Debt repaid | $0 | $0 | $16.7M | $0 | — |
| Tax withholding on stock comp | $494.0K | $493.0K | $1.2M | $1.4M | $462.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding CLFD as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-12-11 to 2026-07-01
Recent transactions
- Insiders have net sold 23,353 shares over the last 182 days, across 0 purchases and 7 sales.
- Most recent: Beranek Cheryl (Chief Executive Officer) — Open market sale of 1,778 shares on 2026-07-01.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Beranek Cheryl | Chief Executive Officer | Open market sale | 2026-07-01 | 1,778 |
| HERZOG DANIEL R | Chief Financial Officer | Grant / award | 2026-06-30 | 752 |
| Khemakhem Anis | Chief Commercial Officer | Grant / award | 2026-06-30 | 158 |
| Hill John P | Chief Operating Officer | Grant / award | 2026-06-30 | 459 |
| Jones Walter Louis JR | Director | Open market sale | 2026-05-11 | 2,391 |
| Wirsbinski Carol Ann | Director | Grant / award | 2026-02-27 | 2,544 |
| Kelly Catherine T. | Director | Grant / award | 2026-02-27 | 2,544 |
| Sarcevic Ademir | Director | Grant / award | 2026-02-27 | 2,544 |
| SKARVAN KATHLEEN | Director | Grant / award | 2026-02-27 | 2,544 |
| ROTH RONALD G | Director | Grant / award | 2026-02-27 | 2,544 |
| Seidel Rebecca | Director | Grant / award | 2026-02-27 | 2,544 |
| Hayward Donald R. | Director | Open market sale | 2026-02-19 | 3,595 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-01 | Beranek Cheryl | Chief Executive Officer | Open market sale | 1,778 | $40.06 |
| 2026-06-30 | HERZOG DANIEL R | Chief Financial Officer | Grant / award | 752 | $24.78 |
| 2026-06-30 | Khemakhem Anis | Chief Commercial Officer | Grant / award | 158 | $24.78 |
| 2026-06-30 | Hill John P | Chief Operating Officer | Grant / award | 459 | $24.78 |
| 2026-06-30 | Beranek Cheryl | Chief Executive Officer | Grant / award | 210 | $24.78 |
| 2026-06-09 | Khemakhem Anis | Chief Commercial Officer | Open market sale | 1,684 | $39.90 |
| 2026-06-01 | Beranek Cheryl | Chief Executive Officer | Open market sale | 7,500 | $46.92 |
| 2026-05-27 | Beranek Cheryl | Chief Executive Officer | Open market sale | 2,500 | $50.00 |
| 2026-05-11 | Beranek Cheryl | Chief Executive Officer | Open market sale | 2,500 | $45.02 |
| 2026-05-11 | Jones Walter Louis JR | Director | Open market sale | 2,391 | $46.05 |
| 2026-05-08 | Beranek Cheryl | Chief Executive Officer | Open market sale | 5,000 | $40.27 |
| 2026-05-06 | Khemakhem Anis | Chief Commercial Officer | Tax withholding | 635 | $30.28 |
| 2026-02-27 | Wirsbinski Carol Ann | Director | Grant / award | 2,544 | $0.00 |
| 2026-02-27 | Kelly Catherine T. | Director | Grant / award | 2,544 | $0.00 |
| 2026-02-27 | Jones Walter Louis JR | Director | Grant / award | 2,544 | $0.00 |
| 2026-02-27 | Sarcevic Ademir | Director | Grant / award | 2,544 | $0.00 |
| 2026-02-27 | SKARVAN KATHLEEN | Director | Grant / award | 2,544 | $0.00 |
| 2026-02-27 | ROTH RONALD G | Director | Grant / award | 2,544 | $0.00 |
| 2026-02-27 | Seidel Rebecca | Director | Grant / award | 2,544 | $0.00 |
| 2026-02-19 | Hayward Donald R. | Director | Open market sale | 3,595 | $32.00 |
| 2025-12-31 | Khemakhem Anis | Chief Commercial Officer | Grant / award | 131 | $24.78 |
| 2025-12-31 | Beranek Cheryl | Chief Executive Officer | Grant / award | 210 | $24.78 |
| 2025-12-31 | Hill John P | Chief Operating Officer | Grant / award | 222 | $24.78 |
| 2025-12-31 | HERZOG DANIEL R | Chief Financial Officer | Grant / award | 88 | $24.78 |
| 2025-12-15 | ROTH RONALD G | Director | Open market purchase | 10,000 | $30.06 |
| 2025-12-11 | Beranek Cheryl | Chief Executive Officer | Gift | 1,960 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 00:35 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-20 | 8-K | 2026-10-15 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-07-28 | 8-K | 2026-07-24 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-09 | View on SEC.gov → |
| 2026-06-03 | 4 | 2026-06-01 | View on SEC.gov → |
| 2026-05-28 | 4 | 2026-05-27 | View on SEC.gov → |
Recent news
Headlines about CLFD (Clearfield, Inc.). Links open the publisher — we don’t host full articles.
-
Trading Systems Reacting to (CLFD) Volatility
Stock Traders Daily · 2026-10-21 -
CLFD 8-K & SEC Filings
Yahoo Finance · 2026-10-21 -
MarketBeat cites USD 41.75 target for Clearfield stock
AD HOC NEWS · 2026-10-20 -
CLFD Nov 2026 30.000 call (CLFD261120C00030000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-20 -
Clearfield CEO Cheryl Beranek Announces Retirement Effective March 31, 2027
Kalkine Media · 2026-10-20 -
Form 8K Clearfield Inc For: 20 October By Investing.com
Investing.com Nigeria · 2026-10-20 -
Clearfield Elementary “All-Clear” of Cockroaches
GantNews.com · 2026-10-20 -
Clearfield CEO Cheri Beranek to retire
TipRanks · 2026-10-20
No headlines in this category right now — try “All”.